Dow University of Health Sciences, Karachi, Pakistan.
Disaster Med Public Health Prep. 2020 Aug;14(4):e9-e10. doi: 10.1017/dmp.2020.230. Epub 2020 Jul 7.
The incidence of extensively drug-resistant tuberculosis (XDR-TB) has been rising consistently in Pakistan, and the country is likely to experience another surge of cases in the midst of the COVID-19 crisis. It is imperative to consider how the rising proportion of XDR-TB is best tackled during the pandemic; this includes finding a solution to the problem of non-adherence at the level of community-based healthcare, the utility and practicality of simultaneous testing for COVID-19 and TB, and reconciliation of the World Health Organization's recommendation of home-based treatment with the need for frequent monitoring of anti-tubercular therapy in XDR-TB. Operational research is needed expeditiously to bypass these limitations.
巴基斯坦广泛耐药结核病（XDR-TB）的发病率一直在持续上升，该国很可能在 COVID-19 危机期间再次出现病例激增。当务之急是考虑如何在大流行期间最好地解决 XDR-TB 比例不断上升的问题；这包括在社区医疗保健层面找到解决不遵医嘱问题的方法，同时检测 COVID-19 和结核病的实用性和可行性，以及协调世界卫生组织推荐的居家治疗与 XDR-TB 中频繁监测抗结核治疗的需求。需要迅速进行运营研究来规避这些限制。
